Clinical Trial Update: Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 001 [Phase 1]

View source ↗

Summary

Phase 1 trial of Group ACYW135 meningococcal polysaccharide vaccine 001 by Hualan Biological Engineering, Inc. has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis

Drugs mentioned

• Group ACYW135 meningococcal polysaccharide vaccine 001

Snippet

Sponsor: Hualan Biological Engineering, Inc. | Conditions: Meningitis | Phase 1 | Status: COMPLETED